G-CSF treatment in decompensated liver disease: a double-edged sword?
作者信息
Engelmann Cornelius, Berg Thomas
机构信息
Department of Hepatology and Gastroenterology, Campus Virchow-Klinikum, Charité-Universitaetsmedizin Berlin, Berlin, Germany.
Berlin Institute of Health (BIH), Berlin, Germany.
出版信息
Hepatol Int. 2022 Oct;16(5):979-982. doi: 10.1007/s12072-022-10379-8. Epub 2022 Sep 2.
Abstract
摘要
相似文献
1
G-CSF treatment in decompensated liver disease: a double-edged sword?粒细胞集落刺激因子（G-CSF）治疗失代偿期肝病：一把双刃剑？
Hepatol Int. 2022 Oct;16(5):979-982. doi: 10.1007/s12072-022-10379-8. Epub 2022 Sep 2.
2
Granulocyte colony-stimulating factors (G-CSF) and Covid-19: a double-edged sword?粒细胞集落刺激因子（G-CSF）与新型冠状病毒肺炎（COVID-19）：一把双刃剑？
Infez Med. 2020 Sep 1;28(3):459-460.
3
Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: double-edged swords.
J Am Coll Cardiol. 2005 Nov 1;46(9):1649-50. doi: 10.1016/j.jacc.2005.08.010.
4
Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial.亚急性ST段抬高型心肌梗死后晚期血运重建时粒细胞集落刺激因子诱导的自体骨髓干细胞动员：G-CSF-STEMI（粒细胞集落刺激因子ST段抬高型心肌梗死）试验的最终结果
J Am Coll Cardiol. 2006 Oct 17;48(8):1712-21. doi: 10.1016/j.jacc.2006.07.044. Epub 2006 Sep 11.
5
Granulocyte-colony stimulating factor administration for neurological improvement in patients with postrehabilitation chronic incomplete traumatic spinal cord injuries: a double-blind randomized controlled clinical trial.粒细胞集落刺激因子对康复后慢性不完全性创伤性脊髓损伤患者神经功能改善的作用：一项双盲随机对照临床试验
J Neurosurg Spine. 2018 Jul;29(1):97-107. doi: 10.3171/2017.11.SPINE17769. Epub 2018 Apr 27.
6
7
The effects of granulocyte-colony stimulating factor on chronic liver disease: a meta-analysis.粒细胞集落刺激因子对慢性肝病的影响：一项荟萃分析。
J Infect Dev Ctries. 2022 Mar 31;16(3):537-546. doi: 10.3855/jidc.14961.
8
Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis.粒细胞集落刺激因子（G-CSF）和粒细胞-巨噬细胞集落刺激因子（GM-CSF）治疗脓毒症：一项荟萃分析。
Crit Care. 2011;15(1):R58. doi: 10.1186/cc10031. Epub 2011 Feb 10.
9
Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy.大剂量环磷酰胺癌症治疗后粒细胞巨噬细胞集落刺激因子与粒细胞集落刺激因子的比较效果
J Clin Oncol. 1996 Feb;14(2):628-35. doi: 10.1200/JCO.1996.14.2.628.
10
Concurrent administration of granulocyte colony-stimulating factor or granulocyte-monocyte colony-stimulating factor enhances the biological activity of rituximab in a severe combined immunodeficiency mouse lymphoma model.在重症联合免疫缺陷小鼠淋巴瘤模型中，同时给予粒细胞集落刺激因子或粒细胞-单核细胞集落刺激因子可增强利妥昔单抗的生物活性。
Leuk Lymphoma. 2005 Dec;46(12):1775-84. doi: 10.1080/17402520500182329.
引用本文的文献
1
MK2 Inhibition as a Novel Treatment for Fibrosis in Primary Sclerosing Cholangitis via an IL-22-Dependent Mechanism.通过白细胞介素-22依赖性机制抑制MK2作为原发性硬化性胆管炎纤维化的新型治疗方法。
Cells. 2025 Jul 5;14(13):1031. doi: 10.3390/cells14131031.
2
Cytopenias in Autoimmune Liver Diseases-A Review.自身免疫性肝病中的血细胞减少症——综述
J Clin Med. 2025 Mar 4;14(5):1732. doi: 10.3390/jcm14051732.
3
Mendelian randomization does not support the effects of G CSF on decompensated liver disease.孟德尔随机化不支持粒细胞集落刺激因子对失代偿性肝病的影响。
Clin Mol Hepatol. 2025 Jul;31(3):e254-e258. doi: 10.3350/cmh.2025.0172. Epub 2025 Mar 4.
4
Namodenoson at the Crossroad of Metabolic Dysfunction-Associated Steatohepatitis and Hepatocellular Carcinoma.纳莫德森处于代谢功能障碍相关脂肪性肝炎与肝细胞癌的十字路口
Biomedicines. 2024 Apr 11;12(4):848. doi: 10.3390/biomedicines12040848.
5
Efficacy of Granulocyte Colony-Stimulating Factor in Acute on Chronic Liver Failure: A Systematic Review and Survival Meta-Analysis.粒细胞集落刺激因子在慢性肝衰竭急性发作中的疗效：一项系统评价与生存meta分析
J Clin Med. 2023 Oct 16;12(20):6541. doi: 10.3390/jcm12206541.
Zotero 插件